ARPC5

ARPC5 encodes the smallest subunit (p16-Arc) of the Arp2/3 complex and is essential for branched actin nucleation, with its N-terminal tail contacting Arp2 and undergoing allosteric release upon NPF binding to shift the complex toward its active conformation (PMID:40042350). ARPC5 and its paralog ARPC5L incorporate into compositionally distinct Arp2/3 complexes with non-redundant cellular functions: ARPC5-containing complexes preferentially drive cytoplasmic actin dynamics, DNA-replication-stress-induced nuclear actin polymerization, and macrophage phagocytosis, whereas ARPC5L-containing complexes mediate TCR-triggered nuclear actin polymerization via nuclear calcium–calmodulin and N-WASP signaling (PMID:36662867, PMID:37162507). ARPC5 activity is regulated post-translationally by MAPKAPK2 phosphorylation at Ser77 and by PKC-dependent phosphorylation that controls MTOC polarity during directed cell migration (PMID:12829704, PMID:21281821). Germline biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and function across immune cell lineages and selectively impair IL-6 classical signaling, establishing ARPC5 deficiency as a cause of immune dysregulation (PMID:37349293).

1. 2003 High

   The discovery that mammalian cells harbor two ARPC5 isoforms (ARPC5 and ARPC5L) that each co-purify with Arp2/3 complexes established that compositionally distinct Arp2/3 complexes exist, raising the question of whether these isoforms have specialized functions.

   Evidence Affinity purification of Arp2/3 from neutrophil extract with isoform-specific antibodies and co-localization in C2C12 cells

   PMID:12451597

   Open questions at the time

   • Functional differences between ARPC5- and ARPC5L-containing complexes were not yet addressed
   • Tissue-specific expression patterns not characterized
2. 2003 High

   Identifying MAPKAPK2-mediated phosphorylation of ARPC5 at Ser77 — specific to the A isoform and occurring within intact Arp2/3 complexes — established the first post-translational regulatory input into the Arp2/3 complex through its smallest subunit.

   Evidence In vitro kinase assay with recombinant MAPKAPK2; S77A mutagenesis; Co-IP of intact complex from neutrophil lysates

   PMID:12829704

   Open questions at the time

   • Functional consequence of Ser77 phosphorylation on actin nucleation or cell behavior was not determined
   • In vivo phosphorylation kinetics unknown
3. 2011 High

   Demonstrating that PKC phosphorylates ARPC5 to control MTOC polarity and directional migration in smooth muscle cells established a second kinase pathway regulating ARPC5 and linked Arp2/3 to microtubule organization during cell migration.

   Evidence Phosphoproteomic MS identification; non-phosphorylatable mutant disrupts MTOC polarity and migration in neointimal SMCs

   PMID:21281821

   Open questions at the time

   • Specific phosphorylation site(s) targeted by PKC not mapped to single residue
   • Whether PKC acts on ARPC5 within assembled Arp2/3 or free subunit not resolved
4. 2012 High

   An unexpected non-cytoskeletal role was revealed when ARPC5 was shown to suppress translation initiation and facilitate mRNA transport to chromatoid bodies in male germ cells, with loss of function impairing spermatid differentiation and fertility.

   Evidence Genetic loss-of-function in mouse germ cells; polysome profiling; chromatoid body localization; fertility phenotyping

   PMID:22447776

   Open questions at the time

   • Whether translational suppression requires Arp2/3 complex assembly or is an independent ARPC5 function remains unclear
   • Mechanism of 80S formation block not structurally defined
5. 2023 High

   Cryo-electron tomography of branch junctions and isoform-selective knockouts revealed that ARPC5 and ARPC5L differentially stabilize ArpC1 at branches and differentially position Ena/VASP proteins, explaining their non-redundant effects on actin assembly and migration.

   Evidence Isoform-selective KO cells; cryo-ET of branch junctions; FRAP and live-cell imaging

   PMID:36662867

   Open questions at the time

   • How Ena/VASP recruitment is differentially specified at the molecular level is not resolved
   • Whether differential branch stability translates to distinct network architectures in vivo remains untested
6. 2023 High

   Isoform-specific knockdowns in CD4 T cells showed that ARPC5 drives cytoplasmic actin dynamics and DNA-damage-induced nuclear actin polymerization, whereas ARPC5L mediates TCR-triggered nuclear actin polymerization through nuclear calcium–calmodulin and N-WASP, establishing stimulus-specific nuclear roles for each isoform.

   Evidence Isoform-specific siRNA in T cells; live nuclear/cytoplasmic actin imaging; pathway epistasis with calmodulin and N-WASP inhibitors

   PMID:37162507

   Open questions at the time

   • How ARPC5L-containing complexes are selectively imported into the nucleus is unknown
   • Downstream nuclear targets of isoform-specific actin polymerization not identified
7. 2023 High

   Human germline biallelic ARPC5 null mutations proved that ARPC5 is essential for Arp2/3 complex integrity across immune lineages, with reconstitution rescuing complex assembly, and revealed a selective impairment of IL-6 classical (but not trans-) signaling, linking ARPC5 deficiency to immune dysregulation.

   Evidence Patient-derived cells with null ARPC5; in vitro reconstitution rescue; IL-6 classical vs. trans-signaling assays

   PMID:37349293

   Open questions at the time

   • Mechanism by which ARPC5 loss selectively impairs IL-6 classical signaling is not defined
   • Full clinical spectrum of ARPC5 deficiency not delineated
8. 2025 High

   High-resolution cryo-EM structures revealed the allosteric mechanism by which NPF binding to Arp2 releases ARPC5's N-terminal tail, closes Arp2's ATP cleft, and initiates partial rotation toward the active state — mechanistically distinct from NPF binding at Arp3.

   Evidence Cryo-EM at 2.9 Å resolution comparing two NPF-bound structural states

   PMID:40042350

   Open questions at the time

   • Whether Ser77 phosphorylation by MAPKAPK2 modulates N-terminal tail release or allosteric activation has not been tested structurally
   • Full activation trajectory including short-pitch dimer formation not captured

• The functional consequences of ARPC5 Ser77 phosphorylation on Arp2/3 activation kinetics and branched actin nucleation remain unknown, and the structural basis for isoform-selective nuclear import and stimulus-specific actin polymerization has not been determined.
• No in vitro reconstitution of phospho-ARPC5 effects on actin nucleation
• Structural basis for ARPC5 vs. ARPC5L functional divergence at atomic resolution not established
• Whether the translational suppressor role in germ cells depends on intact Arp2/3 complex remains untested